Literature DB >> 22679300

It is time to rethink juvenile idiopathic arthritis classification and nomenclature.

Alberto Martini1.   

Abstract

Juvenile idiopathic arthritis (JIA) is not a disease, but an exclusion diagnosis that encompasses all forms of arthritis that begin before the age of 16 years, persist for more than 6 weeks, and are of unknown origin. This heterogeneous group of chronic arthritides has been classified on clinical and laboratory grounds to try to identify homogeneous, mutually exclusives categories suitable for etiopathogenic studies . Recent advances have shown that while some JIA categories identify quite definite disease entities, others still include heterogeneous conditions. Some aspects of JIA classification and nomenclature need therefore to be reconsidered.

Entities:  

Mesh:

Year:  2012        PMID: 22679300     DOI: 10.1136/annrheumdis-2012-201388

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  44 in total

Review 1.  The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.

Authors:  Wendy Gidman; Rachel Meacock; Deborah Symmons
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

2.  Remission rate is not dependent on the presence of antinuclear antibodies in juvenile idiopathic arthritis.

Authors:  M Glerup; T Herlin; M Twilt
Journal:  Clin Rheumatol       Date:  2017-01-17       Impact factor: 2.980

3.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

4.  [Juvenile idiopathic arthritis. Thoughts on the current classification].

Authors:  H-I Huppertz
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

Review 5.  The Challenges and Opportunities of Classifying Childhood Arthritis.

Authors:  Dax G Rumsey; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2020-01-11       Impact factor: 4.592

Review 6.  Heading toward a modern imaging approach in juvenile idiopathic arthritis.

Authors:  Stefano Lanni; Alberto Martini; Clara Malattia
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

7.  Frequency of joint involvement in juvenile idiopathic arthritis during a 5-year follow-up of newly diagnosed patients: implications for MR imaging as outcome measure.

Authors:  Robert Hemke; Charlotte M Nusman; Désirée M F M van der Heijde; Andrea S Doria; Taco W Kuijpers; Mario Maas; Marion A J van Rossum
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 8.  Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.

Authors:  Hongbin Li; Irina Abramova; Sandra Chesoni; Qingping Yao
Journal:  Clin Rheumatol       Date:  2018-06-17       Impact factor: 2.980

9.  Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  Mark Gorelik; Ndate Fall; Mekibib Altaye; Michael G Barnes; Susan D Thompson; Alexei A Grom; Raphael Hirsch
Journal:  J Rheumatol       Date:  2013-05-15       Impact factor: 4.666

10.  Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.

Authors:  Jeffrey A Dvergsten; Robert G Mueller; Patricia Griffin; Sameem Abedin; Allyson Pishko; Joshua J Michel; Margalit E Rosenkranz; Ann M Reed; Daniel A Kietz; Abbe N Vallejo
Journal:  Arthritis Rheum       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.